Biopure Receives Notice of Nasdaq Delisting
June 30 2009 - 8:30AM
PR Newswire (US)
CAMBRIDGE, Mass., June 30 /PRNewswire-FirstCall/ -- Biopure
Corporation (NASDAQ:BPUR) announced that it has received notice
from The Nasdaq Stock Market, by letter dated June 24, 2009, that
it is out of compliance with the Nasdaq Marketplace Rules and its
common stock may be delisted. The notice stated that the company no
longer meets the minimum of $2,500,000 in stockholders' equity for
continued listing on the Nasdaq Capital Market. Nasdaq advised that
the company has 15 calendar days to submit a plan to regain
compliance. If such plan is accepted, Nasdaq may grant an extension
of up to 105 days from the date of notification to regain
compliance. If the Company is unable to regain compliance its
common stock will be delisted. The company does not intend to
submit a plan to regain compliance. Biopure Corporation Biopure
Corporation develops and markets pharmaceuticals, called oxygen
therapeutics, that are intravenously administered to deliver oxygen
to the body's tissues. The company has limited remaining cash. It
is exploring the potential sale of some, substantially all, or all
of its assets, and is evaluating liquidation. Contact: Zaf
Zafirelis Biopure Corporation (617) 234-6500 DATASOURCE: Biopure
Corporation CONTACT: Zaf Zafirelis of Biopure Corporation,
+1-617-234-6500,
Copyright
Biopure (MM) (NASDAQ:BPUR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Biopure (MM) (NASDAQ:BPUR)
Historical Stock Chart
From Apr 2023 to Apr 2024